Inactive Instrument

Avisa Diagnostics Inc. Stock price Canadian Securities Exchange

Equities

MKU.H

CA05380J1075

Biotechnology & Medical Research

Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 81 21-04-19
Director of Finance/CFO 58 21-06-21
Chief Tech/Sci/R&D Officer - 21-06-01
Members of the board TitleAgeSince
Chief Executive Officer 81 21-04-19
Director/Board Member 64 21-04-19
Director/Board Member 51 21-04-19
More insiders
Avisa Diagnostics Inc. is a clinical-stage medical device company. The Company is engaged in the development of the Allora BreathTest (ABT), a drug/device biomarker technology platform. The Allora BreathTest (ABT) is an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of bacterial load. ABT enables the ultra-rapid detection of virulent bacterial pathogens, detecting and monitoring bacterial load after the patient inhales or ingests its drug substrates via its own delivery systems. Its ABT portfolio includes Post-Covid-19 Bronchiectasis, Develo, Ventilator-Associated Pneumonia (VAP), Chronic Obstructive Pulmonary Disease (COPD), Community-Acquired, Pneumonia (CAP), Cystic Fibrosis, Tuberculosis, Aspergillus Fungus and Clostridium Difficile (C. diff).
More about the company
  1. Stock
  2. Equities
  3. Stock Avisa Diagnostics Inc.
  4. Stock Avisa Diagnostics Inc. - Canadian Securities Exchange